AMBCrypto12h
State of the Metaverse – Are MANA, SAND, and AXS poised for revival?
Once the stars of the crypto market, metaverse tokens like MANA, SAND, and AXS have struggled lately. The metaverse once ...
AXIS Capital (NYSE:AXS) Price Target Raised to $118.00
AXIS Capital (NYSE:AXS – Get Free Report) had its price objective lifted by Keefe, Bruyette & Woods from $115.00 to $118.00 ...
KBW Sticks to Their Buy Rating for Axis Capital (AXS)
KBW analyst Meyer Shields maintained a Buy rating on Axis Capital (AXS – Research Report) today and set a price target of $118.00. The ...
Axsome Therapeutics Announces FDA Pre-NDA Meeting Minutes for AXS-05 in Alzheimer’s Disease Agitation Supporting NDA Submission
Supplemental New Drug Application (sNDA) submission anticipated in 3Q 2025NEW YORK, March 03, 2025 (GLOBE NEWSWIRE) -- Axsome ...
Zacks Research Reduces Earnings Estimates for AXIS Capital
Investment analysts at Zacks Research cut their Q1 2025 earnings per share estimates for shares of AXIS Capital in a research ...
Axsome Therapeutics expects to submit sNDA for AXS-05 in Q3
Axsome Therapeutics (AXSM) has received formal pre-New Drug Application meeting minutes from the U.S. Food and Drug Administration supporting a ...
FintechNewsSG3d
High AXS Payments Forced Chocolate Finance to Adjust Miles Rewards, Instant Withdrawals
Chocolate Finance paused instant withdrawals due to a surge in AXS bill payments, driven by users maximising its miles reward ...
Zacks Investment Research on MSN21h
Will Auvelity & Other Drugs Aid AXSM's Growth Amid Stiff Competition?
Axsome Therapeutics’ AXSM Auvelity (AXS-05) was launched in the United States in 2022 for the treatment of major depressive disorder (MDD), making it the first approved drug in the company’s portfolio ...